Navigation Links
VISULAS 690s Photodynamic Therapy Laser System

ProductsVISULAS 690s Photodynamic Therapy Laser System
Company Carl Zeiss Meditec, Inc.
Item VISULAS 690s Photodynamic Therapy Laser System
Features 
  • Latest Technology: Twenty years of laser manufacturing legacy is behind the unique features of the laser to ensure safety, efficiency, and treatment accuracy.
  • Universal Slit Lamp Compatibility: Seamless integration between ZEISS and Haag-Streit slit lamps without the need of recalibration or realignment.
  • Portability: The compact and portable design facilitates growth with your expanding practice.
Description The VISULAS 690s is the benchmark for photodynamic therapy. As the instrument of choice for the international phase III Visudyne clinical trials, Carl Zeiss has leveraged its 20 year legacy in laser manufacturing to create the photodynamic therapy laser trusted by the world's leading ophthalmologists.
Info Carl Zeiss Meditec, Inc.Call Carl Zeiss Meditec, Inc. to buy products (US and Canada only; other locations use number below) USACanada1-866-407-6044

Customer Service: 877-486-7473
Web site: http://www.meditec.zeiss.com/

Related medicine products :

1. VISULAS 532s
2. VISULAS YAG III Laser Capsulotomy Systems
3. VISULAS YAG III Combi Complete Laser Therapy System
4. Activa Therapy System
5. VNS Therapy System
6. Cold Shoulder™ Therapy Wrap
7. InterStim Therapy -- Sacral Nerve Stimulation (SNS) for Urinary Control
8. Osbon ErecAid Vacuum Therapy System - Automatic
9. Osbon ErecAid Vacuum Therapy System - Manual
10. Osbon ErecAid Vacuum Therapy System - Classic
11. ErecAid® Esteem™ External Vacuum Therapy System
Breaking Medicine News(10 mins):Health News:Beating Heart Differs by Gender, Age: Study 2Health News:Many Dialysis Patients Get Wrong Blood Thinners for Angioplasty 2Health News:Many Dialysis Patients Get Wrong Blood Thinners for Angioplasty 3Health News:Review Questions Tamiflu's Effectiveness 2Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 2Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 3Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 4Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 5Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 6Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 7Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 8Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 9Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 10Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 11Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 12Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 13Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 14Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 15Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 16Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 17Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 18Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 19Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 20Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 21Health News:Reportlinker Adds Japanese Market for Women's Health Devices 2009 2Health News:Reportlinker Adds Japanese Market for Women's Health Devices 2009 3Health News:Reportlinker Adds Japanese Market for Women's Health Devices 2009 4Health News:Reportlinker Adds Japanese Market for Women's Health Devices 2009 5Health News:Reportlinker Adds Japanese Market for Women's Health Devices 2009 6Health News:Reportlinker Adds Japanese Market for Women's Health Devices 2009 7Health News:Reportlinker Adds Japanese Market for Women's Health Devices 2009 8Health News:Reportlinker Adds Japanese Market for Women's Health Devices 2009 9Health News:Reportlinker Adds Japanese Market for Women's Health Devices 2009 10Health News:Reportlinker Adds Japanese Market for Women's Health Devices 2009 11Health News:Reportlinker Adds Japanese Market for Women's Health Devices 2009 12
Other Medicine News:Health News:Lung Cancer Alliance Calls American Cancer Society's Claim of Progress Selective 2Health News:Hospital Car Parking Fees Top the List of Life's Biggest Injustices 2Health News:The Pill Kills Women: Largest Protest Against Birth Control Pill 2Health News:ALIMTA(R) (pemetrexed for injection) Receives Positive Opinion From CHMP as Maintenance Therapy for Nonsquamous Non-Small Cell Lung Cancer 2Health News:ALIMTA(R) (pemetrexed for injection) Receives Positive Opinion From CHMP as Maintenance Therapy for Nonsquamous Non-Small Cell Lung Cancer 3Health News:ALIMTA(R) (pemetrexed for injection) Receives Positive Opinion From CHMP as Maintenance Therapy for Nonsquamous Non-Small Cell Lung Cancer 4Health News:ALIMTA(R) (pemetrexed for injection) Receives Positive Opinion From CHMP as Maintenance Therapy for Nonsquamous Non-Small Cell Lung Cancer 5Health News:ALIMTA(R) (pemetrexed for injection) Receives Positive Opinion From CHMP as Maintenance Therapy for Nonsquamous Non-Small Cell Lung Cancer 6Health News:ALIMTA(R) (pemetrexed for injection) Receives Positive Opinion From CHMP as Maintenance Therapy for Nonsquamous Non-Small Cell Lung Cancer 7Health News:Monterey Mushrooms Launches Vitamin D Enriched Sun Grill-A-Bella and White Mushrooms 2Health News:The Female Health Company Switches to the NASDAQ Stock Market 2Health News:The Female Health Company Switches to the NASDAQ Stock Market 3
Breaking Medicine Technology:Reportlinker Adds Prepackaged Medical Kits and Trays - A World Market Analysis 2Reportlinker Adds Prepackaged Medical Kits and Trays - A World Market Analysis 3Reportlinker Adds Prepackaged Medical Kits and Trays - A World Market Analysis 4Reportlinker Adds Prepackaged Medical Kits and Trays - A World Market Analysis 5Reportlinker Adds Prepackaged Medical Kits and Trays - A World Market Analysis 6Reportlinker Adds Prepackaged Medical Kits and Trays - A World Market Analysis 7Reportlinker Adds Prepackaged Medical Kits and Trays - A World Market Analysis 8Reportlinker Adds Prepackaged Medical Kits and Trays - A World Market Analysis 9Reportlinker Adds Respiratory Care Equipment & Supplies - A Worldwide Market Review 2Reportlinker Adds Respiratory Care Equipment & Supplies - A Worldwide Market Review 3Reportlinker Adds Respiratory Care Equipment & Supplies - A Worldwide Market Review 4Reportlinker Adds Respiratory Care Equipment & Supplies - A Worldwide Market Review 5Reportlinker Adds Respiratory Care Equipment & Supplies - A Worldwide Market Review 6Reportlinker Adds Respiratory Care Equipment & Supplies - A Worldwide Market Review 7Reportlinker Adds Respiratory Care Equipment & Supplies - A Worldwide Market Review 8Reportlinker Adds Respiratory Care Equipment & Supplies - A Worldwide Market Review 9Remote Technologies Improve Patient Care, Viable Alternative to Intensivist Shortage 2Remote Technologies Improve Patient Care, Viable Alternative to Intensivist Shortage 35 Year Study Published in Diabetologia Demonstrated Long Term Safety of Lantus 28R 29 Compared to NPH 4685 15 Year Study Published in Diabetologia Demonstrated Long Term Safety of Lantus 28R 29 Compared to NPH 4685 25 Year Study Published in Diabetologia Demonstrated Long Term Safety of Lantus 28R 29 Compared to NPH 4685 35 Year Study Published in Diabetologia Demonstrated Long Term Safety of Lantus 28R 29 Compared to NPH 4685 45 Year Study Published in Diabetologia Demonstrated Long Term Safety of Lantus 28R 29 Compared to NPH 4685 5Health Integrated Hosts Industry Collaborative Focused on the Patient Centered Medical Home 28PCMH 29 50737 1Health Integrated Hosts Industry Collaborative Focused on the Patient Centered Medical Home 28PCMH 29 50737 2Health Integrated Hosts Industry Collaborative Focused on the Patient Centered Medical Home 28PCMH 29 50737 3NeoStem Inc Appoints International Expert in Endocrinology and Pharmacology as Vice President of Drug Development and Regulatory Affairs 50735 1NeoStem Inc Appoints International Expert in Endocrinology and Pharmacology as Vice President of Drug Development and Regulatory Affairs 50735 2NeoStem Inc Appoints International Expert in Endocrinology and Pharmacology as Vice President of Drug Development and Regulatory Affairs 50735 3NeoStem Inc Appoints International Expert in Endocrinology and Pharmacology as Vice President of Drug Development and Regulatory Affairs 50735 4